HEADER TRANSFERASE 22-SEP-08 3ELJ
TITLE JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR.
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 8;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK1, C-JUN N-TERMINAL
COMPND 5 KINASE 1, JNK-46;
COMPND 6 EC: 2.7.11.24;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MAPK8, JNK1, PRKM8;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX 6P1
KEYWDS C-JUN N-TERMINAL KINASE, MITOGEN-ACTIVATED PROTEIN KINASE, ATP-
KEYWDS 2 BINDING, KINASE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN,
KEYWDS 3 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, JNK1
EXPDTA X-RAY DIFFRACTION
AUTHOR S.CHAMBERLAIN,C.ATKINS,F.DEANDA,M.DUMBLE,R.GERDING,A.GROY,
AUTHOR 2 S.KORENCHUK,R.KUMAR,H.LEI,R.MOOK,G.MOORTHY,A.REDMAN,J.ROWLAND,
AUTHOR 3 L.SHEWCHUK,G.VICENTINI,J.MOSLEY
REVDAT 4 06-SEP-23 3ELJ 1 REMARK SEQADV
REVDAT 3 13-JUL-11 3ELJ 1 VERSN
REVDAT 2 06-JAN-09 3ELJ 1 JRNL
REVDAT 1 30-DEC-08 3ELJ 0
JRNL AUTH S.D.CHAMBERLAIN,A.M.REDMAN,J.W.WILSON,F.DEANDA,J.B.SHOTWELL,
JRNL AUTH 2 R.GERDING,H.LEI,B.YANG,K.L.STEVENS,A.M.HASSELL,L.M.SHEWCHUK,
JRNL AUTH 3 M.A.LEESNITZER,J.L.SMITH,P.SABBATINI,C.ATKINS,A.GROY,
JRNL AUTH 4 J.L.ROWAND,R.KUMAR,R.A.MOOK,G.MOORTHY,S.PATNAIK
JRNL TITL OPTIMIZATION OF 4,6-BIS-ANILINO-1H-PYRROLO[2,3-D]PYRIMIDINE
JRNL TITL 2 IGF-1R TYROSINE KINASE INHIBITORS TOWARDS JNK SELECTIVITY.
JRNL REF BIOORG.MED.CHEM.LETT. V. 19 360 2009
JRNL REFN ISSN 0960-894X
JRNL PMID 19071018
JRNL DOI 10.1016/J.BMCL.2008.11.077
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.2.0019
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.76
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 3 NUMBER OF REFLECTIONS : 35293
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.188
REMARK 3 R VALUE (WORKING SET) : 0.187
REMARK 3 FREE R VALUE : 0.215
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1871
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85
REMARK 3 REFLECTION IN BIN (WORKING SET) : 2545
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.53
REMARK 3 BIN R VALUE (WORKING SET) : 0.2150
REMARK 3 BIN FREE R VALUE SET COUNT : 133
REMARK 3 BIN FREE R VALUE : 0.2480
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2783
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 34
REMARK 3 SOLVENT ATOMS : 325
REMARK 3
REMARK 3 B VALUES.
REMARK 3 B VALUE TYPE : LIKELY RESIDUAL
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.95
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.97000
REMARK 3 B22 (A**2) : -0.55000
REMARK 3 B33 (A**2) : -0.42000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.133
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.121
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.650
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3071 ; 0.007 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4196 ; 1.041 ; 1.984
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 383 ; 5.053 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 137 ;34.898 ;24.307
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 537 ;12.199 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;15.174 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 452 ; 0.067 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2461 ; 0.003 ; 0.020
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1446 ; 0.188 ; 0.200
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2180 ; 0.299 ; 0.200
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 279 ; 0.118 ; 0.200
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 52 ; 0.105 ; 0.200
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 22 ; 0.109 ; 0.200
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1927 ; 0.573 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3039 ; 0.807 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1343 ; 1.251 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1157 ; 1.957 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 1 A 112
REMARK 3 ORIGIN FOR THE GROUP (A): 18.7320 13.9920 41.8980
REMARK 3 T TENSOR
REMARK 3 T11: -0.0296 T22: -0.0506
REMARK 3 T33: -0.0649 T12: -0.0128
REMARK 3 T13: 0.0019 T23: 0.0092
REMARK 3 L TENSOR
REMARK 3 L11: 1.3060 L22: 1.4382
REMARK 3 L33: 1.8652 L12: -0.2573
REMARK 3 L13: 0.4106 L23: -0.4525
REMARK 3 S TENSOR
REMARK 3 S11: -0.0580 S12: 0.0060 S13: 0.0998
REMARK 3 S21: 0.1640 S22: -0.0567 S23: -0.0691
REMARK 3 S31: -0.0268 S32: 0.0509 S33: 0.1147
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 113 A 365
REMARK 3 ORIGIN FOR THE GROUP (A): 15.3640 15.7380 15.6750
REMARK 3 T TENSOR
REMARK 3 T11: -0.0603 T22: -0.0590
REMARK 3 T33: -0.0413 T12: 0.0009
REMARK 3 T13: -0.0066 T23: -0.0008
REMARK 3 L TENSOR
REMARK 3 L11: 0.5007 L22: 0.5875
REMARK 3 L33: 1.3841 L12: 0.0837
REMARK 3 L13: 0.2312 L23: 0.1705
REMARK 3 S TENSOR
REMARK 3 S11: -0.0076 S12: 0.0060 S13: 0.0551
REMARK 3 S21: 0.0459 S22: 0.0467 S23: -0.0425
REMARK 3 S31: -0.0554 S32: 0.0097 S33: -0.0391
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3ELJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-08.
REMARK 100 THE DEPOSITION ID IS D_1000049473.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 22-NOV-06
REMARK 200 TEMPERATURE (KELVIN) : 93
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID14-4
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35293
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800
REMARK 200 RESOLUTION RANGE LOW (A) : 59.760
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 200 DATA REDUNDANCY : 3.200
REMARK 200 R MERGE (I) : 0.09600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5
REMARK 200 DATA REDUNDANCY IN SHELL : 3.60
REMARK 200 R MERGE FOR SHELL (I) : 0.19100
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 2Q01
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 46.94
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3350, 0.1M SODIUM HEPES, 15%
REMARK 280 GYLCEROL ADDED AS A CRYOPROTECTANT PRIOR TO FREEZING., PH 7.5,
REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.37250
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.34600
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.73250
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.34600
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.37250
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.73250
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A -4
REMARK 465 PRO A -3
REMARK 465 LEU A -2
REMARK 465 GLY A -1
REMARK 465 SER A 0
REMARK 465 MET A 1
REMARK 465 SER A 2
REMARK 465 ARG A 3
REMARK 465 SER A 4
REMARK 465 LYS A 5
REMARK 465 ARG A 6
REMARK 465 ALA A 173
REMARK 465 ARG A 174
REMARK 465 THR A 175
REMARK 465 ALA A 176
REMARK 465 GLY A 177
REMARK 465 THR A 178
REMARK 465 ASP A 339
REMARK 465 LYS A 340
REMARK 465 GLN A 341
REMARK 465 LEU A 342
REMARK 465 ASP A 343
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 7 CG OD1 OD2
REMARK 470 ASP A 17 CG OD1 OD2
REMARK 470 LYS A 30 CD CE NZ
REMARK 470 LYS A 68 CE NZ
REMARK 470 LYS A 96 CD CE NZ
REMARK 470 SER A 179 OG
REMARK 470 LYS A 222 CE NZ
REMARK 470 LYS A 250 CG CD CE NZ
REMARK 470 LYS A 273 CE NZ
REMARK 470 LYS A 336 CG CD CE NZ
REMARK 470 GLU A 344 CG CD OE1 OE2
REMARK 470 GLU A 346 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 102 -62.49 -125.70
REMARK 500 GLN A 102 -56.36 -129.95
REMARK 500 ARG A 150 -14.77 76.44
REMARK 500 CYS A 163 5.18 80.04
REMARK 500 ALA A 282 27.19 -155.58
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GS7 A 365
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3EKK RELATED DB: PDB
REMARK 900 RELATED ID: 3EKN RELATED DB: PDB
DBREF 3ELJ A 1 364 UNP P45983 MK08_HUMAN 1 364
SEQADV 3ELJ GLY A -4 UNP P45983 EXPRESSION TAG
SEQADV 3ELJ PRO A -3 UNP P45983 EXPRESSION TAG
SEQADV 3ELJ LEU A -2 UNP P45983 EXPRESSION TAG
SEQADV 3ELJ GLY A -1 UNP P45983 EXPRESSION TAG
SEQADV 3ELJ SER A 0 UNP P45983 EXPRESSION TAG
SEQRES 1 A 369 GLY PRO LEU GLY SER MET SER ARG SER LYS ARG ASP ASN
SEQRES 2 A 369 ASN PHE TYR SER VAL GLU ILE GLY ASP SER THR PHE THR
SEQRES 3 A 369 VAL LEU LYS ARG TYR GLN ASN LEU LYS PRO ILE GLY SER
SEQRES 4 A 369 GLY ALA GLN GLY ILE VAL CYS ALA ALA TYR ASP ALA ILE
SEQRES 5 A 369 LEU GLU ARG ASN VAL ALA ILE LYS LYS LEU SER ARG PRO
SEQRES 6 A 369 PHE GLN ASN GLN THR HIS ALA LYS ARG ALA TYR ARG GLU
SEQRES 7 A 369 LEU VAL LEU MET LYS CYS VAL ASN HIS LYS ASN ILE ILE
SEQRES 8 A 369 GLY LEU LEU ASN VAL PHE THR PRO GLN LYS SER LEU GLU
SEQRES 9 A 369 GLU PHE GLN ASP VAL TYR ILE VAL MET GLU LEU MET ASP
SEQRES 10 A 369 ALA ASN LEU CYS GLN VAL ILE GLN MET GLU LEU ASP HIS
SEQRES 11 A 369 GLU ARG MET SER TYR LEU LEU TYR GLN MET LEU CYS GLY
SEQRES 12 A 369 ILE LYS HIS LEU HIS SER ALA GLY ILE ILE HIS ARG ASP
SEQRES 13 A 369 LEU LYS PRO SER ASN ILE VAL VAL LYS SER ASP CYS THR
SEQRES 14 A 369 LEU LYS ILE LEU ASP PHE GLY LEU ALA ARG THR ALA GLY
SEQRES 15 A 369 THR SER PHE MET MET THR PRO TYR VAL VAL THR ARG TYR
SEQRES 16 A 369 TYR ARG ALA PRO GLU VAL ILE LEU GLY MET GLY TYR LYS
SEQRES 17 A 369 GLU ASN VAL ASP LEU TRP SER VAL GLY CYS ILE MET GLY
SEQRES 18 A 369 GLU MET VAL CYS HIS LYS ILE LEU PHE PRO GLY ARG ASP
SEQRES 19 A 369 TYR ILE ASP GLN TRP ASN LYS VAL ILE GLU GLN LEU GLY
SEQRES 20 A 369 THR PRO CYS PRO GLU PHE MET LYS LYS LEU GLN PRO THR
SEQRES 21 A 369 VAL ARG THR TYR VAL GLU ASN ARG PRO LYS TYR ALA GLY
SEQRES 22 A 369 TYR SER PHE GLU LYS LEU PHE PRO ASP VAL LEU PHE PRO
SEQRES 23 A 369 ALA ASP SER GLU HIS ASN LYS LEU LYS ALA SER GLN ALA
SEQRES 24 A 369 ARG ASP LEU LEU SER LYS MET LEU VAL ILE ASP ALA SER
SEQRES 25 A 369 LYS ARG ILE SER VAL ASP GLU ALA LEU GLN HIS PRO TYR
SEQRES 26 A 369 ILE ASN VAL TRP TYR ASP PRO SER GLU ALA GLU ALA PRO
SEQRES 27 A 369 PRO PRO LYS ILE PRO ASP LYS GLN LEU ASP GLU ARG GLU
SEQRES 28 A 369 HIS THR ILE GLU GLU TRP LYS GLU LEU ILE TYR LYS GLU
SEQRES 29 A 369 VAL MET ASP LEU GLU
HET GS7 A 365 45
HETNAM GS7 2-FLUORO-6-{[2-({2-METHOXY-4-[(METHYLSULFONYL)
HETNAM 2 GS7 METHYL]PHENYL}AMINO)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-
HETNAM 3 GS7 YL]AMINO}BENZAMIDE
FORMUL 2 GS7 C22 H21 F N6 O4 S
FORMUL 3 HOH *325(H2 O)
HELIX 1 1 PRO A 60 GLN A 62 5 3
HELIX 2 2 ASN A 63 VAL A 80 1 18
HELIX 3 3 LEU A 115 GLN A 120 1 6
HELIX 4 4 ASP A 124 ALA A 145 1 22
HELIX 5 5 LYS A 153 SER A 155 5 3
HELIX 6 6 ALA A 193 LEU A 198 1 6
HELIX 7 7 ASN A 205 HIS A 221 1 17
HELIX 8 8 ASP A 229 GLY A 242 1 14
HELIX 9 9 CYS A 245 LYS A 250 1 6
HELIX 10 10 GLN A 253 ARG A 263 1 11
HELIX 11 11 SER A 270 PHE A 275 1 6
HELIX 12 12 PRO A 276 PHE A 280 5 5
HELIX 13 13 SER A 284 LEU A 302 1 19
HELIX 14 14 SER A 311 HIS A 318 1 8
HELIX 15 15 ILE A 321 TYR A 325 5 5
HELIX 16 16 ASP A 326 GLU A 331 1 6
HELIX 17 17 THR A 348 ASP A 362 1 15
SHEET 1 A 2 PHE A 10 ILE A 15 0
SHEET 2 A 2 SER A 18 LEU A 23 -1 O SER A 18 N ILE A 15
SHEET 1 B 5 TYR A 26 GLY A 35 0
SHEET 2 B 5 GLY A 38 ASP A 45 -1 O ALA A 42 N LYS A 30
SHEET 3 B 5 ARG A 50 SER A 58 -1 O VAL A 52 N ALA A 43
SHEET 4 B 5 ASP A 103 GLU A 109 -1 O VAL A 104 N LEU A 57
SHEET 5 B 5 ASN A 90 PHE A 92 -1 N ASN A 90 O VAL A 107
SHEET 1 C 3 ALA A 113 ASN A 114 0
SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113
SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158
SITE 1 AC1 18 ILE A 32 GLY A 33 SER A 34 GLY A 35
SITE 2 AC1 18 VAL A 40 ALA A 53 GLU A 109 MET A 111
SITE 3 AC1 18 ASP A 112 ALA A 113 ASN A 114 GLN A 117
SITE 4 AC1 18 SER A 155 ASN A 156 LEU A 168 HOH A 507
SITE 5 AC1 18 HOH A 518 HOH A 605
CRYST1 50.745 71.465 108.692 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019707 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013993 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009200 0.00000